✦ LIBER ✦

Once-daily dosing of timolol in hypertension: A controlled study

✍ Scribed by I. R. Edwards; O. Else

Publisher: Springer
Year: 1980
Tongue: English
Weight: 357 KB
Volume: 17
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00625796

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once daily propranolol in the treatment

Once daily propranolol in the treatment of mild to moderate hypertension

✍ A. P. Douglas-Jones; N. S. Baber; A. Lee 📂 Article 📅 1978 🏛 Springer 🌐 English ⚖ 336 KB

Antihypertensive effect of once daily su

Antihypertensive effect of once daily sustained release isradipine: a placebo controlled cross-over study

✍ F. Arzilli; E. Gandolfi; C. Prato; P. Innocenti; F. Ponzanelli; A. Caiazza; F. G 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 318 KB

To evaluate the magnitude and duration of the antihypertensive effect of sustained release (SRO) isradipine, 37 uncomplicated essential hypertensive patients (diastolic blood pressure 100-115 mm Hg after a one month run-in on placebo) were randomised to receive, according to a double-blind cross-ove

A double-blind comparison of once-daily

A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension

✍ Ming-Fong Chen; Chi-Yu Yang; Wen-Jone Chen; Chii-Ming Lee; Chau-Chung Wu; Chiau- 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 537 KB

A dose-finding study of once-daily oral

A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection

✍ Ching-Lung Lai; Seng Gee Lim; Nathaniel A. Brown; Xiao-Jian Zhou; Deborah M. Llo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

Current therapy for chronic hepatitis B is suboptimal as a result of limited durable response rates, cumulative viral resistance, and/or poor tolerability. Telbivudine has potent antiviral activity against hepatitis B virus (HBV) in vitro and in the woodchuck model and has a promising preclinical sa

Prospective randomized study of once-dai

Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections

✍ P. J. de Vries; R. P. Verkooyen; P. Leguit; H. A. Verbrugh 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 945 KB

Gallopamil slow release: a double blind

Gallopamil slow release: a double blind study of twice daily versus once daily treatment in chronic stable angina

✍ H. S. Markus; E. M. F. Chong; R. G. Wilcox 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 290 KB

The clinical efficacy of a new slow release preparation of the calcium antagonist gallopamil was assessed in 20 patients by diary cards and treadmill exercise tests. A single blind phase of two week periods of placebo, gallopamil 100 mg o.d. and gallopamil 100 mg b.i.d., blinded to the patient, was